Most Read Articles
Pearl Toh, 13 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 4 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
Roshini Claire Anthony, Yesterday

The combination of ceftazidime and avibactam proved noninferior to meropenem in adults with nosocomial pneumonia, positioning it as a potential treatment option for this condition, results from the phase III REPROVE* trial show. Nonetheless, the combination was associated with a higher number of safety events compared with meropenem.

Tristan Manalac, Yesterday
Hormone treatment confers beneficial mood effects in postmenopausal women, according to a recent study, which reports that a transdermal oestradiol plus intermittent micronized progesterone (TE+IMP) treatment regimen is more effective than placebo at reducing depressive symptoms in peri- and postmenopausal women.

Swallowing, airway abnormalities common in NNI children with DP

09 Aug 2017

Abnormalities in swallowing and airway function are common in non-neurologically impaired (NNI) paediatric patients with dysphagia (DP), a new study has shown.

Of the 128 NNI paediatric DP patients (median age 6.6 months; 54 percent male), 86 percent (n=110) underwent instrumental swallowing assessment before treatment. Abnormal swallows were observed for 64 percent (n=70).

Full airway endoscopy, performed in 72 patients, showed that laryngomalacia was observed in 29 patients, of whom 14 had type one while 15 had type 2. Type 1 laryngeal cleft was reported in 24 patients.

Gastrointestinal endoscopy was performed in 27 participants and revealed that there was one case of gastritis and four of oesophagitis according to microscopic examination.

Of the participants, 119 were recommended for further treatments which included surgery and modifications in feeding. Furthermore, 66 percent (n=85) of the patients modified the food and liquid consistency while 12 percent (n=15) were put on enteral feeding.

Surgery was performed on 36 percent (n=46) of patients. Of these, 19 patients received injection augmentations using hyaluronic acid-based products, 14 underwent endoscopic repair of the laryngeal cleft and 18 had supraglottoplasty.

After treatment, 79 percent (n=94) achieved symptom resolution and 7 percent (n=8) remained on alternate feeding routes.

Participants were recruited from the Aspiration Clinic at the Stollery Children’s Hospital in Canada. Those that were referred by speech and language pathologists or paediatric otolaryngologists were eligible. Only those without neurological abnormalities that may contribute to DP were included.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 13 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 4 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
Roshini Claire Anthony, Yesterday

The combination of ceftazidime and avibactam proved noninferior to meropenem in adults with nosocomial pneumonia, positioning it as a potential treatment option for this condition, results from the phase III REPROVE* trial show. Nonetheless, the combination was associated with a higher number of safety events compared with meropenem.

Tristan Manalac, Yesterday
Hormone treatment confers beneficial mood effects in postmenopausal women, according to a recent study, which reports that a transdermal oestradiol plus intermittent micronized progesterone (TE+IMP) treatment regimen is more effective than placebo at reducing depressive symptoms in peri- and postmenopausal women.